ConductScience.org, home

Paper41389337

One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy.

Cao X and 5 others. Cancer Metastasis Rev, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy. Papers, record 41389337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41389337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy.
PubMed
Journal
Cancer Metastasis Rev
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.22, provisional
iCite
Revised in PubMed
2026-07-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cao XXuedi
2Guo YYunyun
3Guo ZZhengyang
4Liu YYang
5Dou YYali
6Xue LLixiang

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
CarbonMajor topic
Antineoplastic AgentsMajor topic
Humans
Animals
Metabolic Networks and Pathways

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BYSY2022069Peking University Third Hospital Clinical Key ProjectPubMed
BYSYZD2023010Peking University Third Hospital Clinical Key ProjectPubMed
No. 82303801Youth Program of National Natural Science Foundation of ChinaPubMed
No. 82204678Youth Program of National Natural Science Foundation of ChinaPubMed
2022YFA1104001the National Key Research and Development Program of ChinaPubMed
No.82272745National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References192

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133142801BRCA1-A and BRISC: Multifunctional Molecular Machines for Ubiquitin Signaling.Biomolecules2020https://conductscience.org/library/papers/33142801PubMed
237108312SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.Int J Mol Sci2023https://conductscience.org/library/papers/37108312PubMed
323242140Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.Nature2013https://conductscience.org/library/papers/23242140PubMed
430534944Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.J Natl Cancer Inst2019https://conductscience.org/library/papers/30534944PubMed
527264180Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow.Cell Rep2016https://conductscience.org/library/papers/27264180PubMed
630909399DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents.Molecules2019https://conductscience.org/library/papers/30909399PubMed
724075985A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.Cell Rep2013https://conductscience.org/library/papers/24075985PubMed
836380144Valemetostat Tosilate: First Approval.Drugs2022https://conductscience.org/library/papers/36380144PubMed
939818457Mechanisms and rationales of SAM homeostasis.Trends Biochem Sci2025https://conductscience.org/library/papers/39818457PubMed
1039136771Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon.Cell Mol Life Sci2024https://conductscience.org/library/papers/39136771PubMed
1138848370Hydroxylamine production by Alcaligenes faecalis challenges the paradigm of heterotrophic nitrification.Sci Adv2024https://conductscience.org/library/papers/38848370PubMed
1237875111Methotrexate-based PROTACs as DHFR-specific chemical probes.Cell Chem Biol2024https://conductscience.org/library/papers/37875111PubMed
1334479957Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.Clin Cancer Res2021https://conductscience.org/library/papers/34479957PubMed
1426831078Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26831078PubMed
159245423The homodimeric form of glycine N-methyltransferase acts as a polycyclic aromatic hydrocarbon-binding receptor.Biochemistry1997https://conductscience.org/library/papers/9245423PubMed
1632436060A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.Invest New Drugs2020https://conductscience.org/library/papers/32436060PubMed
1730744688Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/30744688PubMed
1831607565Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation.Cell Metab2019https://conductscience.org/library/papers/31607565PubMed
1934244426p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34244426PubMed
2030365149I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.Oncol Rep2019https://conductscience.org/library/papers/30365149PubMed

See all 192 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42793024The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy.Genes (Basel)2026https://conductscience.org/library/papers/42793024PubMed
42640410Integrated Multi-Omics Analysis of Gut Microbiota-Associated Metabolites and Related Host Molecular Signatures in Cervical Squamous Cell Carcinoma.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/42640410PubMed
42516378One-carbon metabolism in cancer immunity: T-cell fitness, epigenetic programming, and therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42516378PubMed
42417838RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis.Cell Mol Life Sci2026https://conductscience.org/library/papers/42417838PubMed
42357368Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review.Pharmaceutics2026https://conductscience.org/library/papers/42357368PubMed
41899603Crosstalk Between Cis-Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/41899603PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41389337

GET https://conductscience.org/api/papers/v1/41389337/references?page=2